SeekIn receives CE Mark for cancer detection kit

LabPulse.com staff writers
Feb 24, 2022
2019 07 15 18 08 8235 Artificial Intelligence Ai Data 400

SeekIn has received the CE Mark for its SeekInCare cancer detection kit, which is ready to be launched in European markets.

The company has an artificial intelligence (AI)-based platform that uses private and public data to identify weak cancer DNA and protein signals in the blood and trace them back to a tissue of origin. SeekIn also has patents on algorithms to reduce background noise and reveal cancer signals in blood.

Latest in Artificial Intelligence
Ai Woman Social
Roche adds new collaborative AI tools to cancer diagnostics open environment
September 9, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Financials Growth Revenue Business Social
PreciseDx raises $20.7M in series B funding
August 22, 2024
Breast Cancer2 Social
Researchers develop AI model for breast tumor staging
July 25, 2024
Related Stories
Dna Data Ai Social
Proteomics
SeekIn announces validation of AI-enabled multicancer early detection test
Dna Sequencing Data Analysis Social
Sequencing
SeekIn announces CE Mark approval for WGS cancer mutation detection test
2019 05 21 23 51 7032 Blood Cell Clot 400
Leukemia
SeekIn receives CE Mark for karyotyping kit
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Artificial Intelligence
Roche adds new collaborative AI tools to cancer diagnostics open environment
By LabPulse.com staff writers
Roche is integrating more than 20 new artificial intelligence (AI) algorithms from eight new collaborators into its Roche Digital Pathology Open Environment for cancer diagnostics.
September 9, 2024
Ai Woman Social
University of Eastern Finland researchers develop algorithm for better breast cancer screening
By LabPulse.com staff writers
Researchers at the University of Eastern Finland have developed an algorithm to improve mammogram density assessment, with the potential to increase screening accuracy.
August 23, 2024
Breast Mammo Social
PreciseDx raises $20.7M in series B funding
By LabPulse.com staff writers
Oncology diagnostics developer PreciseDx has raised $20.7 million in series B funding, bringing its total funding to date to $31.5 million.
August 22, 2024
Financials Growth Revenue Business Social
Researchers develop AI model for breast tumor staging
By LabPulse.com staff writers
A team of researchers has created an artificial intelligence (AI) model that can identify the different stages of ductal carcinoma in situ, a preinvasive tumor that may progress to a lethal form of breast cancer.
July 25, 2024
Breast Cancer2 Social
GE HealthCare to buy Intelligent Ultrasound's AI business for $51M
By LabPulse.com staff writers
GE HealthCare has reached an agreement to acquire Intelligent Ultrasound's clinical artificial intelligence (AI) software business for approximately $51 million.
July 19, 2024
Business Handshake Intelligence Social
Eden raises $10M for imaging and diagnostics AI
By LabPulse.com staff writers
Eden, a healthcare technology firm specializing in generative artificial intelligence (AI) for medical imaging and diagnostics, has raised $10 million in a recent funding round.
July 18, 2024
Businessman Artificial Intelligence Ai Virtual Screen
Cambridge researchers create predictive model for Alzheimer's disease
By LabPulse.com staff writers
Researchers at Cambridge University have developed an artificial intelligence (AI) model that is effective at predicting if patients who show early dementia symptoms will remain stable or develop Alzheimer's.
July 15, 2024
Woman Dementia Alzheimer Social
WVU to develop at-home apnea detection device
By LabPulse.com staff writers
West Virginia University (WVU) researchers, supported by a U.S. National Science Foundation grant, are developing an at-home sleep apnea detection device.
July 3, 2024
Sleep Apnea 2 Resized
AI-driven liquid biopsy method predicts cancer recurrence
By LabPulse.com staff writers
An artificial intelligence (AI)-guided approach for detecting tumor DNA in blood has shown remarkable sensitivity in predicting cancer recurrence, according to a study published in Nature.
June 17, 2024
Dna Sequencing2
Day Zero shares AI-based approach to antimicrobial susceptibility testing
By LabPulse.com staff writers
A Day Zero Diagnostics research team has unveiled a new approach to antimicrobial susceptibility testing using artificial intelligence (AI) to guide analysis.
June 14, 2024
Bacteria Blood Sepsis Social
Backlog of unresolved medical diagnoses leads to new method for clinical exome reanalysis
By Liz Carey
The automated analysis improved the rate of accurate genetic diagnosis, doubling the number of solved cases as compared with benchmarked methods, across three distinct real-world cohorts, according to researchers.
May 16, 2024
Child Hospital Social
AI-powered endoscope doubles detection of high-risk esophageal lesions
By Nick Paul Taylor
Deep learning has doubled the detection of high-risk lesions during routine endoscopies in a clinical trial of more than 3,000 patients in China.
April 17, 2024
Artificial Intelligence Ai Binary Code Social
Page 1 of 18
Next Page